Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
41.65
+0.80 (1.96%)
At close: Sep 23, 2026, 4:00 PM EDT
38.10
-3.55 (-8.52%)
After-hours: Sep 23, 2026, 6:42 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $4.86 billion as of September 23, 2026. Its market cap has increased by 64.60% in one year.
Market Cap
4.86B
Enterprise Value
4.36B
1-Year Change
64.60%
Ranking
Category
Stock Price
$41.65
ChartMarket Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $4.86B, an increase of 6,169.15%. That is a compound annual growth rate of 43.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.86B | 22.18% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 5.51B |
| Dianthus Therapeutics | 5.50B |
| Erasca | 5.44B |
| Definium Therapeutics | 5.42B |
| Veradermics | 4.94B |
| Edgewise Therapeutics | 4.83B |
| Iovance Biotherapeutics | 4.82B |
| Parabilis Medicines | 4.72B |